跳至主要内容
临床试验/NCT03931135
NCT03931135Unknown不适用

Comparison Between Cyclizine and Dexamethasone for Prevention of Nausea and Vomiting After Intrathecal Morphine in Patients Undergoing Cesarean Section

Assiut University0 个研究点目标入组 160 人开始时间: 2019年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
160
主要终点
Change in Post operative nausea and vomiting after intrathecal morphine by using PONV intensity scale.

研究概览

简要总结

Comparing between cyclizine and dexamethasone in preventing PONV after CS under spinal anesthesia with spinal opiate.

详细描述

Postoperative nausea and vomiting (PONV) is defined as any nausea, retching, or vomiting occurring during the first 24-48 h after surgery in patients. PONV is one of the most common causes of patient dissatisfaction after anesthesia, with reported incidences of 30% in all post-surgical patients and up to 80% in high-risk patients. In addition, PONV is regularly rated in preoperative surveys, as the anesthesia outcome the patient would most like to avoid. While suture dehiscence, aspiration of gastric contents, esophageal rupture, and other serious complications associated with PONV are rare, nausea and vomiting is still an unpleasant and all-too-common postoperative morbidity that can delay patient discharge from the post-anesthesia care unit and increase unanticipated hospital admissions in outpatients.

There are many well-established risk factors for PONV which are classified in two classes:

A) Patient related risk factors:

  1. Female gender is consistently the strongest risk factor for PONV, female patient are three times more likely than men to suffer from PONV.
  2. For adult patient, age is a statistically, though not clinically, relevant risk factor, with the incidence of PONV decreasing as patients age. For pediatric patients, however, age increases the risk of post-operative vomiting (POV), such that children older than 3 years have been shown to have an increased risk of POV compared with children younger than 3 years.
  3. Obesity is a strong risk factor for PONV: patients with body mass index (BMI) more than 30 have the double risk of PONV.
  4. Non-smoking status roughly doubles the patient's risk of PONV. The specific mechanism underlying smoking's protective effect is unknown ,but one of the most commonly believed theories is that polycyclic aromatic hydrocarbons in cigarette smoke induce cytochrome P450 enzyme which increase the metabolism of emetogenic volatile anesthetics.
  5. History of gastrointestinal disease as gastritis, gastric ulcer or duodenal ulcer increases the risk for PONV.
  6. History of motion sickness, Meniere's disease or previous PONV indicates a general susceptibility to PONV.

B) Anesthesia related risk factors:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 18 to 45 years old
  • Parturient
  • Full Term

排除标准

  • Women who has obstetric complications.
  • Women with evidence of foetal compromise.
  • Patients who have gastro-intestinal diseases.
  • Administration of anti-emetic drugs within 24 hours before operation.
  • Patients who have hyperemesis gravidarium

研究组 & 干预措施

Dexamethasone

Active Comparator

干预措施: IV Cyclizine versus IV Dexamethasone for prevention of nausea and vomiting after intrathecal morphine in patients undergoing cesarean section (Drug)

Cyclizine

Active Comparator

干预措施: IV Cyclizine versus IV Dexamethasone for prevention of nausea and vomiting after intrathecal morphine in patients undergoing cesarean section (Drug)

结局指标

主要结局

Change in Post operative nausea and vomiting after intrathecal morphine by using PONV intensity scale.

时间窗: Change in severity of nausea and vomiting 30 minutes , 3 hours, 6 hours after intervention

Nausea and vomiting were recorded as present or absent, All measurements and ratings were completed at the time when patients rated their PONV intensity. We also recorded factors known to be associated with the risk of developing PONV, including known risk factors for PONV.

次要结局

  • Change in postoperative pain (assessed by VAS ).(Immediatly before and after intervention, 30 minutes after intervention, 3 hours after intervention, 6 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mina Elia Azmy Habib

Principal Investigator

Assiut University

相似试验